Generex Biotechnology Publishes Response to Congressional Letter Calling for COVID-19 Challenge Studies and Alternative Solution to Accelerate Vaccine Development

by NASDAQ Market News April 27, 2020

NASDAQ Market News
Click here to email author

Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020

eFFECTOR’s Zotatifin (eFT226) Inhibited Tumor Growth and Caused Tumor Regression Across Diverse Receptor Tyrosine Kinase-Driven Tumor Types in Preclinical Models of Disease

Ads